Acadia Pharmaceuticals Inc. · 3 weeks ago
Executive Long-Term Care Sales Specialist - Knoxville, TN
United States
Full-time
Remote
Mid, Senior Level, Lead/Staff
$124K/yr - $155K/yr
1+ years expAcadia Pharmaceuticals is committed to turning scientific promise into meaningful innovation for underserved neurological and rare disease communities. The Executive Long-Term Care Sales Specialist is responsible for driving sales and managing relationships within the long-term care territory, ensuring appropriate patients are identified and maintained on therapy.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Build and maintain strong relationships with all members of the LTC resident care team, including physicians, physician-extenders (NP/PA), consultant pharmacists, dispensing pharmacists, and nursing facility leadership/staff
Promote Acadia products by delivering compliant clinical, disease state, and reimbursement education tailored to customer needs
Identify and address customer questions, concerns, and objections with advanced selling skills
Develop deep knowledge of customers, practices, and local/regional market trends; apply this insight to business planning
Create and execute quarterly territory business/action plans, leveraging data to maximize reach, frequency, and impact within budget
Provide guidance on pricing, reimbursement, and LTC-specific profitability parameters; act as liaison between customers and Acadia for access-related questions
Collaborate with sales management, territory teammates, and cross-functional partners (e.g., managed markets, marketing, operations, training) to address business needs
Represent Acadia at conferences, exhibits, product launches, and training sessions; contribute to regional and national initiatives
Mentor and train new/junior Sales Specialists; share field insights and participate in cross-functional projects
Maintain compliance with all regulatory requirements, company policies, and LTC regulations affecting medication use and resident care
Qualification
Required
Bachelor's degree required
Minimum 1-2 years of sales experience in pharmaceutical/healthcare
Minimum 5 years of healthcare sales (2+ in complex/account-based selling) for Senior Specialist
Minimum 12 years of healthcare sales (3+ in complex/account-based selling) for Executive Specialist
Advanced selling and negotiation skills, with the ability to influence diverse HCP audiences
Proven leadership, mentorship, and role-model capabilities at a regional level
Strong business acumen, organization, and self-motivation with a business ownership mentality
Must reside within the territory (or within 30 miles of its border) and, if required, within reasonable proximity to a major airport
Valid driver's license with acceptable driving record; ability to drive a company vehicle daily and travel independently by air
Must meet vaccination and facility access requirements for customer visits and event participation
In-depth knowledge of neuroscience, LTC market dynamics, payer systems (Part A, Part D), specialty distribution, and applicable LTC regulations
Ability to position Acadia as a valued partner in the LTC community, earning recognition as a subject-matter expert
Proficiency in Microsoft Office and virtual engagement platforms (e.g., Zoom, WebEx)
Preferred
Life sciences preferred
Neuroscience preferred
Benefits
Competitive base, bonus, new hire and ongoing equity packages
Medical, dental, and vision insurance
Employer-paid life, disability, business travel and EAP coverage
401(k) Plan with a fully vested company match 1:1 up to 5%
Employee Stock Purchase Plan with a 2-year purchase price lock-in
15+ vacation days
13 -15 paid holidays, including office closure between December 24th and January 1st
10 days of paid sick time
Paid parental leave benefit
Tuition assistance
Company
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$811.73MKey Investors
National Institute of Neurological Disorders and StrokeOxford Bioscience PartnersNational Institute of Mental Health
2019-09-17Post Ipo Equity· $287.5M
2018-11-30Post Ipo Equity· $316.25M
2013-01-02Post Ipo Equity· $86.39M
Leadership Team
Catherine Adams
Chief Executive Officer
Steve Davis
President and CEO
Recent News
2025-11-20
Company data provided by crunchbase